Amicus Therapeutics Announces Second Quarter 2016 Financial Results and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amicus Therapeutics Announces Second Quarter 2016 Financial Results and Corporate Updates

Amicus Therapeutics (FOLD) Misses Q2 EPS by 7c

August 9, 2016 7:55 AM EDT

Amicus Therapeutics (NASDAQ: FOLD) reported Q2 EPS of ($0.40), $0.07 worse than the analyst estimate of ($0.33).

2016 Financial Guidance

Cash, cash equivalents, and marketable securities totaled $214.2 million at June 30, 2016. The Companys balance sheet was strengthened during the second quarter of 2016 with $57.8 million in net proceeds under the... More